Evidence map›Paper›PMID 31260155›Full record

ReviewJournal of magnetic resonance imaging : JMRI2020

MRI and PET/MRI in hematologic malignancies.

Marius E Mayerhoefer, Stephen J Archibald, Christina Messiou, Anton Staudenherz, Dominik Berzaczy, Heiko Schöder

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of magnetic resonance imaging : JMRI, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Dalton transactions (Cambridge, England : 2003) · 2024
    Article
  10. PET/MRI in colorectal and anal cancers: an update.Abdominal radiology (New York) · 2023
    Review
  11. Head-to-Head Comparison between FDG andDiagnostics (Basel, Switzerland) · 2023
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. The Role of [Cancers · 2022
    Review
  17. Review
  18. Observational
  19. Article
  20. Applications of PET in Diagnosis and Prognosis of Leukemia.Technology in cancer research & treatment
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Marius E MayerhoeferDepartment of Biomedical Imaging and Image-guided Therapy, Division of General and Pediatric Radiology, Medical University of Vienna, Austria.ORCID 0000-0001-8786-8686
Stephen J ArchibaldPET Research Centre, University of Hull, UK.
Christina MessiouDepartment of Radiology, Royal Marsden Hospital and Institute of Cancer Research, Sutton, UK.
Anton StaudenherzDepartment of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Austria.
Dominik BerzaczyDepartment of Biomedical Imaging and Image-guided Therapy, Division of General and Pediatric Radiology, Medical University of Vienna, Austria.
Heiko SchöderDepartment of Radiology, Memorial Sloan Kettering Cancer Center New York, New York, USA.
Medical University of Vienna · ATMemorial Sloan Kettering Cancer Center · USRoyal Marsden NHS Foundation Trust · GBUniversity of Hull · GB

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

The role of MRI differs considerably between the three main groups of hematological malignancies: lymphoma, leukemia, and myeloma. In myeloma, whole-body MRI (WB-MRI) is recognized as a highly sensitive test for the assessment of myeloma, and is also endorsed by clinical guidelines, especially for detection and staging. In lymphoma, WB-MRI is presently not recommended, and merely serves as an alternative technique to the current standard imaging test, [

Indexed as

Hematologic NeoplasmsPositron Emission Tomography Computed TomographyChildFluorodeoxyglucose F18HumansMagnetic Resonance ImagingPositron-Emission TomographyRadiopharmaceuticalsWhole Body ImagingFluorodeoxyglucose F18RadiopharmaceuticalsleukemialymphomaMRImyelomaPET

Identifiers

PMID31260155
PMCPMC7217155
OpenAlexW2955260405

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.